Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Differentiation | 7 | 2017 | 79 | 2.030 |
Why?
|
| Adipose Tissue, Brown | 4 | 2017 | 11 | 1.650 |
Why?
|
| Follistatin | 4 | 2017 | 18 | 1.540 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 167 | 1.320 |
Why?
|
| Mice | 10 | 2020 | 508 | 0.790 |
Why?
|
| Animals | 11 | 2020 | 1238 | 0.770 |
Why?
|
| Testosterone | 4 | 2011 | 76 | 0.760 |
Why?
|
| Adipocytes | 2 | 2014 | 26 | 0.720 |
Why?
|
| Adipocytes, Brown | 1 | 2017 | 2 | 0.620 |
Why?
|
| Adipocytes, White | 1 | 2017 | 2 | 0.620 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 2 | 0.620 |
Why?
|
| Energy Metabolism | 2 | 2014 | 12 | 0.610 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 36 | 0.600 |
Why?
|
| Muscle, Skeletal | 5 | 2013 | 87 | 0.560 |
Why?
|
| Female | 7 | 2020 | 1733 | 0.550 |
Why?
|
| Biomarkers | 1 | 2015 | 58 | 0.540 |
Why?
|
| Up-Regulation | 6 | 2020 | 71 | 0.540 |
Why?
|
| Myostatin | 2 | 2013 | 47 | 0.490 |
Why?
|
| Transforming Growth Factor beta | 2 | 2011 | 81 | 0.480 |
Why?
|
| Nitric Oxide | 2 | 2013 | 54 | 0.470 |
Why?
|
| Down-Regulation | 2 | 2013 | 52 | 0.470 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 3 | 0.460 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 3 | 0.460 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 11 | 0.460 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 27 | 0.450 |
Why?
|
| Vitamin D | 1 | 2013 | 21 | 0.450 |
Why?
|
| Cell Proliferation | 2 | 2020 | 110 | 0.440 |
Why?
|
| Muscle Development | 2 | 2011 | 22 | 0.440 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2011 | 7 | 0.430 |
Why?
|
| Receptors, Androgen | 3 | 2011 | 33 | 0.410 |
Why?
|
| Male | 6 | 2017 | 1649 | 0.380 |
Why?
|
| Cells, Cultured | 3 | 2017 | 164 | 0.370 |
Why?
|
| Signal Transduction | 4 | 2017 | 180 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 185 | 0.360 |
Why?
|
| Pluripotent Stem Cells | 2 | 2003 | 7 | 0.300 |
Why?
|
| Neoplastic Stem Cells | 3 | 2020 | 25 | 0.300 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 138 | 0.290 |
Why?
|
| Thermogenesis | 2 | 2017 | 5 | 0.280 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 11 | 0.280 |
Why?
|
| Humans | 6 | 2020 | 2493 | 0.260 |
Why?
|
| Uncoupling Protein 1 | 2 | 2015 | 6 | 0.260 |
Why?
|
| Ion Channels | 2 | 2015 | 7 | 0.260 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 8 | 0.260 |
Why?
|
| Lipid Metabolism | 2 | 2014 | 24 | 0.240 |
Why?
|
| Dihydrotestosterone | 1 | 2003 | 9 | 0.240 |
Why?
|
| Androgens | 1 | 2003 | 29 | 0.240 |
Why?
|
| Mice, Knockout | 2 | 2014 | 112 | 0.240 |
Why?
|
| Transcription Factors | 2 | 2013 | 42 | 0.230 |
Why?
|
| Fibroblasts | 2 | 2014 | 26 | 0.200 |
Why?
|
| Animal Feed | 1 | 2020 | 12 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 11 | 0.200 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 14 | 0.190 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 54 | 0.190 |
Why?
|
| Body Composition | 2 | 2013 | 35 | 0.180 |
Why?
|
| Nicotine | 1 | 2020 | 89 | 0.180 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 4 | 0.160 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 5 | 0.160 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 37 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 93 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2015 | 9 | 0.140 |
Why?
|
| Sulfonamides | 1 | 2015 | 10 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2020 | 102 | 0.130 |
Why?
|
| Smad Proteins | 2 | 2011 | 10 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2011 | 68 | 0.120 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cold Temperature | 1 | 2014 | 2 | 0.120 |
Why?
|
| Proton Ionophores | 1 | 2014 | 2 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 9 | 0.120 |
Why?
|
| Immunoblotting | 1 | 2014 | 12 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 28 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 92 | 0.120 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 2 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 4 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 5 | 0.120 |
Why?
|
| Genotype | 1 | 2013 | 10 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 25 | 0.120 |
Why?
|
| Cell Separation | 1 | 2013 | 3 | 0.120 |
Why?
|
| Retinoid X Receptors | 1 | 2013 | 6 | 0.120 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 6 | 0.120 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 8 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 9 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2013 | 36 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 25 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 24 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 16 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 77 | 0.110 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 2 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 6 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 8 | 0.110 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 5 | 0.110 |
Why?
|
| Obesity | 1 | 2013 | 102 | 0.110 |
Why?
|
| Gene Expression | 1 | 2011 | 73 | 0.100 |
Why?
|
| Disease Progression | 1 | 2010 | 50 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 74 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 9 | 0.080 |
Why?
|
| Myoblasts | 1 | 2008 | 12 | 0.080 |
Why?
|
| Mesoderm | 1 | 2008 | 9 | 0.080 |
Why?
|
| Cell Line | 2 | 2008 | 80 | 0.080 |
Why?
|
| Androstenedione | 1 | 2004 | 6 | 0.070 |
Why?
|
| Hypogonadism | 1 | 2004 | 13 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 22 | 0.060 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 3 | 0.060 |
Why?
|
| Nitriles | 1 | 2003 | 6 | 0.060 |
Why?
|
| Anilides | 1 | 2003 | 5 | 0.060 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 6 | 0.060 |
Why?
|
| Cell Division | 1 | 2003 | 39 | 0.060 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 38 | 0.060 |
Why?
|
| Mecamylamine | 1 | 2020 | 7 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 14 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2020 | 9 | 0.050 |
Why?
|
| Imidazoles | 1 | 2020 | 16 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2020 | 8 | 0.050 |
Why?
|
| Pyridines | 1 | 2020 | 22 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 44 | 0.050 |
Why?
|
| Adult | 2 | 2004 | 807 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 33 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 40 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 24 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 32 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 63 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 120 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2008 | 167 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 16 | 0.020 |
Why?
|
| Kinetics | 1 | 2004 | 44 | 0.020 |
Why?
|
| Ligands | 1 | 2004 | 15 | 0.020 |
Why?
|
| Reference Values | 1 | 2004 | 42 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 12 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2003 | 15 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 45 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2003 | 64 | 0.020 |
Why?
|
| Stem Cells | 1 | 2003 | 28 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 133 | 0.010 |
Why?
|
| Child | 1 | 2003 | 126 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 305 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 799 | 0.010 |
Why?
|